Additional Information
Market: AIM
Sector: Medical
EPIC: AMEI
Latest Price: 0.25  (0,00%)
52-week High: 1.38
52-week Low: 0.20
Market Cap: 1.78M
1 year chart
1 day chart
African Medical Investments
www.africanmedicalinvestments.com

African Medical Investments plc ('AMI') is an AIM listed company (AIM:AMEI) focussed on becoming a leading supplier of private specialist hospitals across Africa offering quality in and outpatient services. Its hospitals fill a crucial role for international standard healthcare demand from the burgeoning middle classes, overseas visitors and multinational corporations, embassies and NGOs designing contingency plans for their executive, workers and expatriate families. The Company currently has three operational private specialist hospitals in: Maputo, Mozambique; Dar es Salaam, Tanzania; and Harare, Zimbabwe. The Board of AMI is also evaluating additional opportunities to develop new services in existing markets and expand through construction, acquisition or investment in private hospitals in new markets.

African Medical Investments more than doubles revenue in first half

3rd Sep 2012, 7:21 am by Jamie Ashcroft
African Medical Investments more than doubles revenue in first half

 

The restructuring initiatives African Medical Investments (LON:AMEI) put in place last year appear to be paying off as the healthcare firm this morning revealed it more than doubled revenues in  the first six months of the year.

Revenues increased 124 per cent to US$12.1 million. The improvement helped reduce first half losses to US$15 million from US$18.8 million.

Operationally, the company said it has continued to make progress in the consolidation of its existing specialist hospital facilities in Maputo, Dar es Salaam and Harare. 

It is also pursuing an expansion strategy in the Mozambique and Zambia to capitalise on growing demand for quality healthcare services.

“The group remains in a period of transition, but the board is confident that case mix optimisation and finalisation of its cost reduction programme will position the group to significantly improve its financial results,” the company said.

Earlier this year it struck a deal to sell its aviation services business for US£1.3 million. And yesterday it announced a new US$1 million funding through the issue of new loan notes to its largest shareholder Harbinger Capital.

The funds will be used to provide additional working capital, which AMEI says is now required following the illegal occupation of its hospital in Harare and the one-off costs associated with the group’s turnaround strategy.

Yesterday AMI said that the cash injection can create the necessary conditions so that future working capital requirements can be met through independent and external means. It did concede however that this would be subject to a prompt resolution to the Harare legal process.

Legal proceedings are currently taking place restore AMI's occupancy and control of the Harare facility following the forcible occupation of the hospital by the former management company led by the previous chief executive, Dr. Vivek Solanki.  

It says it is confident in its legal position and that it will be reinstated to the facility.  

 

No investment advice


Proactive Investors North America Inc, trades as "Proactiveinvestors USA & Canada".


You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.


You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.


From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.


You understand that we may be providing advertising and/or marketing services to companies mentioned on the site. A full list of companies that are paying for services from us, or our affiliated companies in the UK and Australia can be viewed here